(Q44254765)

1 December 2017

Tyrphostins and retinoids cooperate during inhibition of in vitro growth of ovarian cancer cells (English)

1 reference

1 December 2017

1 reference

Thomas W Grunt

1

1 reference

PubMed ID

12490307

1 December 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

1 December 2017

1 reference

1 December 2017

189

1 reference

1 December 2017

2

1 reference

1 December 2017

147-156

1 reference

Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3',5'-monophosphate

1 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900512-8

7 January 2021

A differential requirement for the COOH-terminal region of the epidermal growth factor (EGF) receptor in amphiregulin and EGF mitogenic signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900512-8

7 January 2021

The transcription factor AP-1 is required for EGF-induced activation of rho-like GTPases, cytoskeletal rearrangements, motility, and in vitro invasion of A431 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900512-8

7 January 2021

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900512-8

7 January 2021

Significance of epidermal growth factor receptor in advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900512-8

7 January 2021

Amplification of erbB-4 oncogene occurs less frequently than that of erbB-2 in primary human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900512-8

7 January 2021

Expression of c-erbB3 protein in primary breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900512-8

7 January 2021

c-erbB3 and c-erbB4 expression is a feature of the endocrine responsive phenotype in clinical breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900512-8

7 January 2021

Reduction of both RAR and RXR levels is required to maximally alter sensitivity of CA-OV3 ovarian tumor cells to growth suppression by all-trans-retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900512-8

7 January 2021

Critical role of both retinoid nuclear receptors and retinoid-X-receptors in mediating growth inhibition of ovarian cancer cells by all-trans retinoic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900512-8

7 January 2021

Multifactorial mechanism for the potentiation of cisplatin (CDDP) cytotoxicity by all-trans retinoic acid (ATRA) in human ovarian carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900512-8

7 January 2021

AP-1 function and regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900512-8

7 January 2021

Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900512-8

7 January 2021

Inhibition of transforming growth factor alpha (TGF-alpha)-mediated growth effects in ovarian cancer cell lines by a tyrosine kinase inhibitor ZM 252868.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900512-8

7 January 2021

Tyrosine kinase inhibition: an approach to drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900512-8

7 January 2021

Antiproliferative effects of tyrosine kinase inhibitors (tyrphostins) on human bladder and renal carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900512-8

7 January 2021

Tyrosine kinase inhibitors. 8. An unusually steep structure-activity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900512-8

7 January 2021

A specific inhibitor of the epidermal growth factor receptor tyrosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900512-8

7 January 2021

Glucose-induced tyrosine phosphorylation of p125 in beta cells and pancreatic islets. A novel proximal signal in insulin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900512-8

7 January 2021

The tyrosine kinase inhibitor tyrphostin blocks the cellular actions of nerve growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900512-8

7 January 2021

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900512-8

7 January 2021

Modulation of growth and proliferation in squamous cell carcinoma by retinoic acid: a rationale for combination therapy with chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900512-8

7 January 2021

Effects of retinoic acid and fenretinide on the c-erbB-2 expression, growth and cisplatin sensitivity of breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900512-8

7 January 2021

Retinoids control the expression of c-erbB receptors in breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900512-8

7 January 2021

Involvement of nuclear steroid/thyroid/retinoid receptors and of protein kinases in the regulation of growth and of c-erbB and retinoic acid receptor expression in MCF-7 breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900512-8

7 January 2021

Cancer statistics, 1995.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900512-8

7 January 2021

Relationship of myc protein expression to the phenotype and to the growth potential of HOC-7 ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900512-8

7 January 2021

Macrophage colony-stimulating factor is expressed by an ovarian carcinoma subline and stimulates the c-myc proto-oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900512-8

7 January 2021

Retinoic acid receptors in retinoid responsive ovarian cancer cell lines detected by polymerase chain reaction following reverse transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900512-8

7 January 2021

Synergistic effects of retinoic acid and 8-Cl-cAMP on apoptosis require caspase-3 activation in human ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900512-8

7 January 2021

Tyrosine kinase inhibitor STI571 potentiates the pharmacologic activity of retinoic acid in acute promyelocytic leukemia cells: effects on the degradation of RARalpha and PML-RARalpha

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900512-8

7 January 2021

EGF receptor signaling inhibits keratinocyte apoptosis: evidence for mediation by Bcl-XL

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900512-8

7 January 2021

Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900512-8

7 January 2021

Chemoprevention of breast cancer: the Italian experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900512-8

7 January 2021

Tyrosine kinase signaling pathways control the expression of retinoic acid receptor-alpha in SK-BR-3 breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900512-8

7 January 2021

Decrease in protein tyrosine phosphorylation is associated with F-actin reorganization by retinoic acid in human endometrial adenocarcinoma (RL95-2) cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2802%2900512-8

7 January 2021

10.1016/S0304-3835(02)00512-8

Identifiers

DOI

1 reference

1 December 2017

1 reference

PubMed ID

12490307